Organ donation has rapidly accelerated over the years of which many come from deceased donors Deceased donation comes either from DCD or from brain death #NCSPharmJC

The presented article aimed to prospectively evaluate the hypothesis of hormone replacement in terms of increasing the viability of heart donation in hemodynamically unstable patients #NCSPharmJC

According to the article, when would T4 replacement in a brain-dead patient provide benefit in terms of successful heart donation? #NCSPharmJC Neurocritical Care Society AbdallaAmmar ashly lamosek

Next up, Madeline Burling from North Kansas City Hospital on Optimal Dosing of Levetiracetam for Seizure Prophylaxis in Critically Ill Patients, recently published in Critical Care Medicine Neurocritical Care Society AbdallaAmmar #NCSPharmJC

Does your center routinely obtain levetiracetam levels in patients receiving seizure prophylaxis? #NCSPharmJC Neurocritical Care Society AbdallaAmmar

#NCSPharmJC is happening now (3 PM EST)! Join us on Zoom and engage on X using the hashtag #NCSPharmJC Neurocritical Care Society

Starting off the #NCSPharmJC with a Systematic Review and Meta-Analysis of Early Sz PPX in mild and Moderate TBI Neurocritical Care Society

Which TBI patients do you recommend Sz Ppx in?#NCSPharmJC Colleen Barthol, PharmD, BCCCP, FNCS Keaton Smetana, PharmD, MBA, FNCS, FCCM

The BTF Severe TBI Guidelines,4th Ed and 2024 NCS Guidelines for Sz PPX in Moderate to Severe TBI recommendations #NCSPharmJC Neurocritical Care Society

The goal of the analysis is to determine the association between Sz Ppx and risk reduction for early PTS in mild and moderate TBI #NCSPharmJC Neurocritical Care Society

What percentage of mild or moderate TBI patients at your institution receive seizure prophylaxis? #NCSPharmJC Andy Webb Salia Farrokh, PharmD, BCCCP, FNCS Karen Berger Kimberly Levasseur F

Key takeaway: Sz ppx may be effective in preventing early PTS in mild and moderate TBI. The small effect size and low rates of early PTS may limit its broader applicability. #NCSPharmJC Neurocritical Care Society

Changing over to intra-arterial tenecteplase following endovascular reperfusion for LVO AIS #NCSPharmJC Neurocritical Care Society

LVO: Pathophysiology and 2018 AHA/ASA Early Stroke Management Guidelines #NCSPharmJC Neurocritical Care Society

In your current practice, do you administer any form of intra–arterial thrombolytics following mechanical thrombectomy #NCSPharmJC Neurocritical Care Society Andy Webb Eljim Salia Farrokh, PharmD, BCCCP, FNCS Casey C. May, PharmD, BCCCP, FNCS Gabe Fontaine

Existing Literature: #HERMES, #CHOICE and #POST-TNK #NCSPharmJC Neurocritical Care Society

Existing Literature: #HERMES, #CHOICE and #POST-TNK #NCSPharmJC Neurocritical Care Society

The objective of the study is to evaluate if intra–arterial tenecteplase administered after EVT would provide a benefit to patients with LVO #NCSPharmJC Neurocritical Care Society

No statistically significant outcomes regarding efficacy and safety outcomes #NCSPharmJC Neurocritical Care Society

Key takeaway: Intra-arterial tenecteplase following MT for LVO did not improve the risk of being disability-free at 90 days #NCSPharmJC Neurocritical Care Society